Cempra
Chapel Hill, North Carolina, United States
About Cempra
Cempra seeks to discover and develop well-differentiated medicines that cure bacterial infections and improve the quality of life for those with chronic illnesses. The company balances near-term product development opportunities, including the macrolide CEM-101, while investing in future products from new technologies to derive the next generation of antibiotics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $108.1M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2012)
- Ticker: nasdaq:CEMP
- Website: cempra.com
- Phone: (919)313-6601
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cempra-2610929 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.